BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1869297)

  • 1. Effect of selective muscarinic receptor agonists and antagonists on active-avoidance learning acquisition in rats.
    Sen AP; Bhattacharya SK
    Indian J Exp Biol; 1991 Feb; 29(2):136-9. PubMed ID: 1869297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermic response of selective muscarinic agonists and antagonists in rat.
    Sen AP; Bhattacharya SK
    Indian J Exp Biol; 1991 Feb; 29(2):131-5. PubMed ID: 1869296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of muscarinic receptor agonists and antagonists on response of non-extensor rats to maximal electroshock.
    Bhattacharya SK; Sen AP; Mitra SK
    Indian J Exp Biol; 1991 Mar; 29(3):237-40. PubMed ID: 1874538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease.
    Fisher A; Brandeis R; Karton I; Pittel Z; Gurwitz D; Haring R; Sapir M; Levy A; Heldman E
    J Pharmacol Exp Ther; 1991 Apr; 257(1):392-403. PubMed ID: 2019998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in rats.
    Shannon HE; Hart JC; Bymaster FP; Calligaro DO; DeLapp NW; Mitch CH; Ward JS; Fink-Jensen A; Sauerberg P; Jeppesen L; Sheardown MJ; Swedberg MD
    J Pharmacol Exp Ther; 1999 Aug; 290(2):901-7. PubMed ID: 10411607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of muscarinic receptor agonists and antagonists on rat brain serotonergic activity.
    Bhattacharya SK; Sen AP
    J Neural Transm Gen Sect; 1992; 90(3):241-7. PubMed ID: 1283683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The amygdala modulates morphine-induced state-dependent memory retrieval via muscarinic acetylcholine receptors.
    Rezayof A; Khajehpour L; Zarrindast MR
    Neuroscience; 2009 May; 160(2):255-63. PubMed ID: 19272427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central muscarinic receptor subtypes and carrageenin-induced paw oedema in rats.
    Bhattacharya SK; Sen AP; Das Gupta G; Seth K; Seth PK
    Res Exp Med (Berl); 1991; 191(1):65-76. PubMed ID: 1674619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex.
    Forray C; el-Fakahany EE
    Mol Pharmacol; 1990 Jun; 37(6):893-902. PubMed ID: 2163015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinergic drugs regulate passive avoidance performance via the amygdala.
    Riekkinen P; Riekkinen M; Sirviö J
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1484-92. PubMed ID: 8263810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of muscarinic receptor agonists and antagonists on swim-stress-induced 'behavioural despair' in rats.
    Bhattacharya SK; Sen AP
    J Psychopharmacol; 1991 Jan; 5(1):77-81. PubMed ID: 22282123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
    Watson M; Yamamura HI; Roeske WR
    J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M; Waelbroeck M; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the mechanism for the relaxation of rat duodenum mediated via M1 muscarinic receptors.
    Hamrouni AM; Gudka N; Broadley KJ
    Auton Autacoid Pharmacol; 2006 Jul; 26(3):275-84. PubMed ID: 16879493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine.
    Flynn DD; Mash DC
    J Pharmacol Exp Ther; 1989 Aug; 250(2):573-81. PubMed ID: 2760841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic receptor-mediated phosphoinositide hydrolysis in the rat retina.
    Moroi-Fetters SE; Neff NH; Hadjiconstantinou M
    J Pharmacol Exp Ther; 1988 Aug; 246(2):553-7. PubMed ID: 2841451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic and nicotinic modulation of cortical acetylcholine release monitored by in vivo microdialysis in freely moving adult rats.
    Quirion R; Richard J; Wilson A
    Synapse; 1994 Jun; 17(2):92-100. PubMed ID: 8091306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of morphine state-dependent learning by muscarinic cholinergic receptors of the ventral tegmental area.
    Darbandi N; Rezayof A; Zarrindast MR
    Physiol Behav; 2008 Jul; 94(4):604-10. PubMed ID: 18479719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative behavioral and neurochemical activities of cholinergic antagonists in rats.
    Bymaster FP; Heath I; Hendrix JC; Shannon HE
    J Pharmacol Exp Ther; 1993 Oct; 267(1):16-24. PubMed ID: 7901390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.